{"id":7532,"date":"2025-01-13T08:41:37","date_gmt":"2025-01-13T16:41:37","guid":{"rendered":"https:\/\/highfieldbio.com\/?p=7532"},"modified":"2025-01-13T08:47:55","modified_gmt":"2025-01-13T16:47:55","slug":"studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases","status":"publish","type":"post","link":"https:\/\/highfieldbio.com\/zh\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/","title":{"rendered":"HighField Biopharmaceuticals \u7684\u7814\u7a76\u663e\u793a\u8102\u8d28\u7ed3\u6784\u8bbe\u8ba1\u5bf9\u5c06 LNP \u975e\u75c5\u6bd2\u57fa\u56e0\u7597\u6cd5\u5e94\u7528\u4e8e\u590d\u6742\u75be\u75c5\u5177\u6709\u4f18\u52bf"},"content":{"rendered":"
\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

2025 \u5e74 1 \u6708 13 \u65e5 | HighField Bio \u65b0\u95fb\u7a3f<\/p><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

HighField Biopharmaceuticals \u7684\u7814\u7a76\u663e\u793a\u8102\u8d28\u7ed3\u6784\u8bbe\u8ba1\u5bf9\u5c06 LNP \u975e\u75c5\u6bd2\u57fa\u56e0\u7597\u6cd5\u5e94\u7528\u4e8e\u590d\u6742\u75be\u75c5\u5177\u6709\u4f18\u52bf<\/h2><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u7814\u7a76\u8bba\u6587\u91cd\u70b9\u5173\u6ce8\u4e86 LNP \u7ed3\u6784\u548c\u6ce8\u5c04\u9014\u5f84\u5728\u5f00\u53d1\u66f4\u597d\u7684 LNP \u975e\u75c5\u6bd2\u57fa\u56e0\u7597\u6cd5\uff08\u7528\u4e8e\u6cbb\u7597\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u548c\u4ee3\u8c22\u7d0a\u4e71\uff0c\u5982\u7cd6\u5c3f\u75c5\uff09\u4e2d\u7684\u91cd\u8981\u6027\u3002<\/i><\/strong><\/p>

\u8fd9\u4e9b\u7814\u7a76\u8fd8\u663e\u793a\u4e86 HighField \u72ec\u7279\u7684\u57fa\u4e8e\u8102\u8d28\u7684\u836f\u7269\u5f00\u53d1\u5e73\u53f0\u5728\u8bbe\u8ba1\u6297\u4f53\u5076\u8054\u7684 tLNP \u7528\u4e8e T \u7ec6\u80de\u3001B \u7ec6\u80de\u3001NK \u7ec6\u80de\u3001\u5185\u76ae\u7ec6\u80de\u548c\u9020\u8840\u5e72\u7ec6\u80de\u57fa\u56e0\u7f16\u8f91\u65b9\u9762\u7684\u6f5c\u529b\u3002<\/i><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u4e2d\u56fd\u676d\u5dde\u2014\u2014\uff08\u5546\u4e1a\u65b0\u95fb<\/a>)\u2013HighField Biopharmaceuticals \u662f\u4e00\u5bb6\u4e34\u5e8a\u9636\u6bb5\u516c\u53f8\uff0c\u4f7f\u7528\u8102\u8d28\u7597\u6cd5\u6cbb\u7597\u764c\u75c7\u548c\u5176\u4ed6\u75be\u75c5\uff0c\u4eca\u5929\u5ba3\u5e03\u53d1\u8868\u4e24\u7bc7\u79d1\u5b66\u671f\u520a\u6587\u7ae0\uff0c\u63ed\u793a LNP \u7ed3\u6784\u8bbe\u8ba1\u7684\u91cd\u8981\u6027\u00a0<\/i>\u5728\u00a0\u4f53\u5185\u00a0<\/i>LNPs \u5728\u9012\u9001 RNA \u5206\u5b50\u4e2d\u7684\u884c\u4e3a\u3002<\/p>

\u5728\u7814\u7a76\u4e2d\u00a0\u300a\u63a7\u91ca\u6742\u5fd7\u300b\uff08JRC\uff09\u00a0<\/i>\u548c\u00a0\u836f\u7269\u7814\u7a76<\/i>\u00a0\u68c0\u67e5\u00a0\u4f53\u5185<\/i>\u00a0mRNA LNP \u75ab\u82d7\u7684\u884c\u4e3a\uff0c\u5e76\u63ed\u793a LNP \u7c92\u5ea6\u3001\u5206\u5e03\u548c\u5185\u90e8\u7ed3\u6784\u5982\u4f55\u5f71\u54cd\u57fa\u56e0\u6cbb\u7597\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002<\/p>

HighField \u9996\u5e2d\u6267\u884c\u5b98\u517c\u79d1\u5b66\u521b\u59cb\u4eba\u5f90\u5b87\u5b8f\u535a\u58eb\u8868\u793a\uff1a\u201cLNP \u5728\u975e\u75c5\u6bd2\u57fa\u56e0\u4f20\u9012\u65b9\u9762\u53d6\u5f97\u4e86\u91cd\u5927\u6210\u529f\uff0c\u5c24\u5176\u662f\u5728 COVID-19 \u75ab\u82d7\u4e2d\uff0c\u4f46\u4eba\u4eec\u5bf9 LNP \u7ed3\u6784\u5982\u4f55\u5f71\u54cd\u751f\u7269\u6d3b\u6027\u77e5\u4e4b\u751a\u5c11\u3002\u201d<\/p>

2024 \u5e74 12 \u6708\u00a0\u65e5\u672c\u65e0\u7ebf\u7535\u901a\u4fe1\u59d4\u5458\u4f1a<\/i>\u00a0\u6587\u7ae0\u6807\u9898\u4e3a\u201cmRNA-LNP\u7ed3\u6784\u7279\u5f81\u7684\u8868\u5f81\u53ca\u589e\u5f3amRNA\u75ab\u82d7\u514d\u75ab\u539f\u6027\u7684\u673a\u5236\uff0c<\/a>\u201d \u5f90\u535a\u58eb\u548c\u5979\u7684\u540c\u4e8b\u8bc4\u8bba\u8bf4\uff0cLNP \u901a\u5e38\u901a\u8fc7\u5176\u7c92\u5ea6\u548c\u591a\u5206\u6563\u6027\u6765\u8868\u5f81\uff0c\u4f46\u8fd9\u4e9b\u7c92\u5b50\u7684\u5185\u90e8\u7ed3\u6784\u5e76\u672a\u5177\u4f53\u8bf4\u660e\u3002<\/p>

\u201c\u6211\u4eec\u7684\u7814\u7a76\u610f\u4e49\u5728\u4e8e\u6211\u4eec\u73b0\u5728\u77e5\u9053 LNP \u7ed3\u6784\u5bf9\u4e8e\u786e\u5b9a mRNA \u5206\u5e03\u548c\u6d3b\u6027\u975e\u5e38\u91cd\u8981\u00a0\u4f53\u5185;<\/i>\u00a0\u8fdc\u6bd4\u7279\u5b9a\u8102\u8d28\u7ed3\u6784\u7684\u8d21\u732e\u66f4\u5927\uff0c\u201d\u5f90\u535a\u58eb\u89e3\u91ca\u9053\u3002<\/p>

\u8fd9\u00a0\u65e5\u672c\u65e0\u7ebf\u7535\u901a\u4fe1\u59d4\u5458\u4f1a\u00a0<\/i>\u8fd9\u9879\u7814\u7a76\u662f\u53e6\u4e00\u7bc7\u8bba\u6587\u7684\u540e\u7eed\u7814\u7a76\uff0c\u9898\u4e3a\u00a0\u9012\u9001\u9014\u5f84\u548c\u7c92\u5f84\u5bf9 mRNA LNPs \u751f\u7269\u5206\u5e03\u548c\u975e\u7ebf\u6027\u57fa\u56e0\u8868\u8fbe\u7684\u5f71\u54cd<\/a>\u3002\u201d\u8fd9\u7bc7\u8bba\u6587\u4f7f\u5f90\u535a\u58eb\u548c\u5979\u7684\u5408\u8457\u8005\u83b7\u5f97\u4e86\u7f8e\u56fd\u5fc3\u7406\u5b66\u4f1a 2024 \u5e74\u836f\u7269\u7814\u7a76\u9ad8\u5f71\u54cd\u529b\u6587\u7ae0\u5956\u3002<\/p>

\u8fd9\u4e24\u9879\u7814\u7a76\u652f\u6301\u4e86 HighField \u8bbe\u8ba1\u5177\u6709\u7a33\u5b9a\u8102\u8d28\u819c\u7ed3\u6784\uff08mLNP\uff09\u548c\u591a\u91cd\u8868\u9762\u951a\u5b9a\u6297\u4f53\uff08tLNP\uff09\u7684 LNP \u7684\u65b9\u6cd5\uff0c\u4ee5\u6269\u5927\u7ec6\u80de\u548c\u57fa\u56e0\u7597\u6cd5\u5728\u5e7f\u6cdb\u590d\u6742\u75be\u75c5\u4e2d\u7684\u5e94\u7528\uff0c\u5e76\u5b9e\u73b0\u6cbb\u7597\u6027\u86cb\u767d\u8d28\u7684\u6301\u7eed\u91ca\u653e\u4ee5\u53ca\u7279\u5b9a\u7ec6\u80de\u7c7b\u578b\u7684\u76f8\u4e92\u4f5c\u7528\u548c\u8f6c\u67d3\u3002<\/p>

HighField \u7684\u975e\u75c5\u6bd2\u57fa\u56e0\u6cbb\u7597\u5019\u9009\u836f\u7269\u5305\u62ec HFG1\uff0c\u4e00\u79cd\u63d0\u4f9b GLP-1R \u6fc0\u52a8\u5242\u8868\u8fbe\u7684 mLNP\uff0c\u7528\u4e8e\u51cf\u80a5\u548c\u6cbb\u7597\u7cd6\u5c3f\u75c5\uff1bHFG2\uff0c\u4e00\u79cd\u7528\u4e8e\u7ec6\u80de\u7279\u5f02\u6027\u57fa\u56e0\u7f16\u8f91\u7684 tLNP\u00a0\u79bb\u4f53<\/i>\u00a0\u548c\u00a0\u4f53\u5185<\/i>.<\/p>

\u5f90\u535a\u58eb\u8868\u793a\uff0c\u8be5\u516c\u53f8\u7684 tLNP \u6709\u53ef\u80fd\u53d6\u4ee3\u91cd\u7ec4\u75c5\u6bd2\uff0c\u7528\u4e8e\u5bf9\u7279\u5b9a\u7ec6\u80de\u7c7b\u578b\uff08\u5982 T \u7ec6\u80de\u3001B \u7ec6\u80de\u3001\u5185\u76ae\u7ec6\u80de\u548c\u9020\u8840\u5e72\u7ec6\u80de\uff09\u8fdb\u884c\u57fa\u56e0\u7f16\u8f91\u3002\u5979\u8865\u5145\u8bf4\uff0cHighField \u4e13\u6ce8\u4e8e\u4ee3\u8c22\u75be\u75c5\u3001\u81ea\u8eab\u514d\u75ab\u548c\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002<\/p>

\u9664\u4e86 tLNP \u5e73\u53f0\u5916\uff0cHighField \u8fd8\u62e5\u6709\u6297\u4f53\u9776\u5411\u8102\u8d28\u4f53\uff08\u514d\u75ab\u8102\u8d28\u4f53\uff09\u00a0LipoADCplex\u5546\u6807<\/sup><\/a>\u00a0\u548c\u00a0TRAF\u4f53\u5546\u6807<\/sup><\/a>\u00a0\u66f4\u5b89\u5168\u3001\u66f4\u6709\u6548\u7684\u764c\u75c7\u514d\u75ab\u6cbb\u7597\u5e73\u53f0\u3002<\/p>

\u5173\u4e8e HighField \u751f\u7269\u5236\u836f<\/b><\/p>

HighField \u662f\u4e00\u5bb6\u4e34\u5e8a\u9636\u6bb5\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u8102\u8d28\u4f53\u7ed3\u6784\u7684\u65b0\u5e94\u7528\uff0c\u4ee5\u98a0\u8986\u73b0\u6709\u7684\u514d\u75ab\u80bf\u7624\u5b66\u548c\u5176\u4ed6\u75be\u75c5\u6280\u672f\u3002\u8be5\u516c\u53f8\u8fd8\u62e5\u6709\u4e00\u4e2a\u7814\u53d1\u4e2d\u5fc3\u548c\u4e00\u4e2a\u7b26\u5408 GMP \u7684\u751f\u4ea7\u8bbe\u65bd\u3002HighField \u7684\u4e3b\u8981\u4e34\u5e8a\u5f00\u53d1\u9879\u76ee\u662f HF1K16\uff0c\u8fd9\u662f\u4e00\u79cd\u836f\u7269\u5305\u88f9\u7684\u514d\u75ab\u8c03\u8282\u8102\u8d28\u4f53\uff0c\u542b\u6709\u5168\u53cd\u5f0f\u89c6\u9ec4\u9178\uff0c\u9776\u5411\u9ad3\u7cfb\u6291\u5236\u7ec6\u80de\uff0c\u7528\u4e8e\u6cbb\u7597\u5b9e\u4f53\u7624\u3002\u8be5\u516c\u53f8\u7684\u4ea7\u54c1\u7ebf\u8fd8\u5305\u62ec\u7528\u4e8e\u5b9e\u4f53\u7624\u764c\u75c7\u7684\u836f\u7269\u5305\u88f9\u514d\u75ab\u8102\u8d28\u4f53\u548c\u7528\u4e8e\u57fa\u56e0\u4f20\u9012\u548c\u57fa\u56e0\u6cbb\u7597\u7684\u8102\u8d28\u7597\u6cd5\u3002\u6709\u5173\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u00a0https:\/\/highfieldbio.com<\/a>.<\/p><\/div>

\u8054\u7cfb\u65b9\u5f0f<\/h2>

\u4e1a\u52a1\u53d1\u5c55\u8054\u7cfb\u4eba\uff1a
\u6c5f\u94f6
jiangxy@hf-biopharm.com<\/a>

\u5a92\u4f53\u8054\u7cfb\u65b9\u5f0f\uff1a
\u4e39\u00b7\u57c3\u62c9\u7c73\u5b89
Opus \u751f\u7269\u6280\u672f\u901a\u8baf
danieleramian@comcast.net<\/a>
425-306-8716<\/p><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

HighField Biopharmaceuticals \u7684\u7814\u7a76\u663e\u793a\u8102\u8d28\u7ed3\u6784\u8bbe\u8ba1\u5728\u5c06 LNP \u975e\u75c5\u6bd2\u57fa\u56e0\u7597\u6cd5\u5e94\u7528\u4e8e\u590d\u6742\u75be\u75c5\u65b9\u9762\u7684\u4f18\u52bf \u7814\u7a76\u8bba\u6587\u91cd\u70b9\u5173\u6ce8 LNP \u7ed3\u6784\u548c\u6ce8\u5c04\u9014\u5f84\u5728\u5f00\u53d1\u66f4\u597d\u7684 LNP \u975e\u75c5\u6bd2\u57fa\u56e0\u7597\u6cd5\uff08\u7528\u4e8e\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u548c\u4ee3\u8c22\u7d0a\u4e71\uff0c\u5982\u7cd6\u5c3f\u75c5\uff09\u65b9\u9762\u7684\u91cd\u8981\u6027\u3002\u8fd9\u4e9b\u7814\u7a76\u8fd8\u663e\u793a\u4e86 HighField \u7684\u6f5c\u529b [\u2026]<\/p>","protected":false},"author":1,"featured_media":7537,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[22],"tags":[],"class_list":["post-7532","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release"],"yoast_head":"\nStudies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex\u00a0Diseases - HighField Biopharmaceuticals<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/highfieldbio.com\/zh\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex\u00a0Diseases - HighField Biopharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex Diseases Research papers focused on the importance of LNP structures and injection route in developing better LNP non-viral gene therapies for autoimmune diseases and metabolic disorders, such as diabetes. The studies also show the potential of HighField\u2019s […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/highfieldbio.com\/zh\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"HighField Biopharmaceuticals\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-13T16:41:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-13T16:47:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"PJWCreative\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/\"},\"author\":{\"name\":\"PJWCreative\",\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/person\/7ec00570bf3fa5a022cd1b08bda3b0f0\"},\"headline\":\"Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex\u00a0Diseases\",\"datePublished\":\"2025-01-13T16:41:37+00:00\",\"dateModified\":\"2025-01-13T16:47:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/\"},\"wordCount\":627,\"publisher\":{\"@id\":\"https:\/\/highfieldbio.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg\",\"articleSection\":[\"Press Release\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/\",\"url\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/\",\"name\":\"Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex\u00a0Diseases - HighField Biopharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\/\/highfieldbio.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg\",\"datePublished\":\"2025-01-13T16:41:37+00:00\",\"dateModified\":\"2025-01-13T16:47:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#primaryimage\",\"url\":\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg\",\"contentUrl\":\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/highfieldbio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex\u00a0Diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/highfieldbio.com\/#website\",\"url\":\"https:\/\/highfieldbio.com\/\",\"name\":\"HighField Bio\",\"description\":\"Lipid-based Therapeutics Targeting the Tumor Microenvironment\",\"publisher\":{\"@id\":\"https:\/\/highfieldbio.com\/#organization\"},\"alternateName\":\"HighField Biopharmaceuticals\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/highfieldbio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/highfieldbio.com\/#organization\",\"name\":\"HighField Biopharmaceuticals, Inc.\",\"alternateName\":\"HighField Bio\",\"url\":\"https:\/\/highfieldbio.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2021\/07\/HIGHfield_logo_horizontal_FINAL_trans.png\",\"contentUrl\":\"https:\/\/highfieldbio.com\/wp-content\/uploads\/2021\/07\/HIGHfield_logo_horizontal_FINAL_trans.png\",\"width\":1500,\"height\":494,\"caption\":\"HighField Biopharmaceuticals, Inc.\"},\"image\":{\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/highfield-biopharma\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/person\/7ec00570bf3fa5a022cd1b08bda3b0f0\",\"name\":\"PJWCreative\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/highfieldbio.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7558191085f3c167c2c5972a9ba86696e53fc4dec7eeb7b3e0cc15866c48b55f?s=80&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7558191085f3c167c2c5972a9ba86696e53fc4dec7eeb7b3e0cc15866c48b55f?s=80&d=mm&r=g\",\"caption\":\"PJWCreative\"},\"sameAs\":[\"https:\/\/highfieldbio.com\"],\"url\":\"https:\/\/highfieldbio.com\/zh\/author\/pjwcreative\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HighField Biopharmaceuticals \u7684\u7814\u7a76\u663e\u793a\u8102\u8d28\u7ed3\u6784\u8bbe\u8ba1\u5728 LNP \u975e\u75c5\u6bd2\u57fa\u56e0\u7597\u6cd5\u5e94\u7528\u4e8e\u590d\u6742\u75be\u75c5\u65b9\u9762\u7684\u4f18\u52bf - HighField Biopharmaceuticals","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/highfieldbio.com\/zh\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/","og_locale":"zh_CN","og_type":"article","og_title":"Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex\u00a0Diseases - HighField Biopharmaceuticals","og_description":"Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex Diseases Research papers focused on the importance of LNP structures and injection route in developing better LNP non-viral gene therapies for autoimmune diseases and metabolic disorders, such as diabetes. The studies also show the potential of HighField\u2019s […]","og_url":"https:\/\/highfieldbio.com\/zh\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/","og_site_name":"HighField Biopharmaceuticals","article_published_time":"2025-01-13T16:41:37+00:00","article_modified_time":"2025-01-13T16:47:55+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg","type":"image\/jpeg"}],"author":"PJWCreative","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#article","isPartOf":{"@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/"},"author":{"name":"PJWCreative","@id":"https:\/\/highfieldbio.com\/#\/schema\/person\/7ec00570bf3fa5a022cd1b08bda3b0f0"},"headline":"Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex\u00a0Diseases","datePublished":"2025-01-13T16:41:37+00:00","dateModified":"2025-01-13T16:47:55+00:00","mainEntityOfPage":{"@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/"},"wordCount":627,"publisher":{"@id":"https:\/\/highfieldbio.com\/#organization"},"image":{"@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg","articleSection":["Press Release"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/","url":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/","name":"HighField Biopharmaceuticals \u7684\u7814\u7a76\u663e\u793a\u8102\u8d28\u7ed3\u6784\u8bbe\u8ba1\u5728 LNP \u975e\u75c5\u6bd2\u57fa\u56e0\u7597\u6cd5\u5e94\u7528\u4e8e\u590d\u6742\u75be\u75c5\u65b9\u9762\u7684\u4f18\u52bf - HighField Biopharmaceuticals","isPartOf":{"@id":"https:\/\/highfieldbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#primaryimage"},"image":{"@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#primaryimage"},"thumbnailUrl":"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg","datePublished":"2025-01-13T16:41:37+00:00","dateModified":"2025-01-13T16:47:55+00:00","breadcrumb":{"@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#primaryimage","url":"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg","contentUrl":"https:\/\/highfieldbio.com\/wp-content\/uploads\/2025\/01\/HIGHIELD_LinkedIn_Research.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/highfieldbio.com\/2025\/01\/13\/studies-by-highfield-biopharmaceuticals-show-advantages-of-lipid-structure-design-for-applying-lnp-non-viral-gene-therapies-to-complex-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/highfieldbio.com\/"},{"@type":"ListItem","position":2,"name":"Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex\u00a0Diseases"}]},{"@type":"WebSite","@id":"https:\/\/highfieldbio.com\/#website","url":"https:\/\/highfieldbio.com\/","name":"\u9ad8\u7530\u751f\u7269","description":"\u9488\u5bf9\u80bf\u7624\u5fae\u73af\u5883\u7684\u8102\u8d28\u7597\u6cd5","publisher":{"@id":"https:\/\/highfieldbio.com\/#organization"},"alternateName":"HighField Biopharmaceuticals","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/highfieldbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/highfieldbio.com\/#organization","name":"\u6d77\u83f2\u5c14\u5fb7\u751f\u7269\u5236\u836f\u6709\u9650\u516c\u53f8","alternateName":"HighField Bio","url":"https:\/\/highfieldbio.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/highfieldbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/highfieldbio.com\/wp-content\/uploads\/2021\/07\/HIGHfield_logo_horizontal_FINAL_trans.png","contentUrl":"https:\/\/highfieldbio.com\/wp-content\/uploads\/2021\/07\/HIGHfield_logo_horizontal_FINAL_trans.png","width":1500,"height":494,"caption":"HighField Biopharmaceuticals, Inc."},"image":{"@id":"https:\/\/highfieldbio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/highfield-biopharma"]},{"@type":"Person","@id":"https:\/\/highfieldbio.com\/#\/schema\/person\/7ec00570bf3fa5a022cd1b08bda3b0f0","name":"PJW\u521b\u610f","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/highfieldbio.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7558191085f3c167c2c5972a9ba86696e53fc4dec7eeb7b3e0cc15866c48b55f?s=80&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7558191085f3c167c2c5972a9ba86696e53fc4dec7eeb7b3e0cc15866c48b55f?s=80&d=mm&r=g","caption":"PJWCreative"},"sameAs":["https:\/\/highfieldbio.com"],"url":"https:\/\/highfieldbio.com\/zh\/author\/pjwcreative\/"}]}},"_links":{"self":[{"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/posts\/7532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/comments?post=7532"}],"version-history":[{"count":7,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/posts\/7532\/revisions"}],"predecessor-version":[{"id":7540,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/posts\/7532\/revisions\/7540"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/media\/7537"}],"wp:attachment":[{"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/media?parent=7532"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/categories?post=7532"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/highfieldbio.com\/zh\/wp-json\/wp\/v2\/tags?post=7532"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}